|
| |
| | 57362 | | 16.03.2007 | | Mepha Pharma AG | | 17.01.2008 | | | | | | | | | | 01.01.30. | | | | 01.01.30. | | IPro |
| Seq.-nr. | Préparation | Description | Forme galénique | Classe d'ATC | |
---|
01 | Fentanyl-Mepha 25 | transdermale Pflaster | Pansement matrice (Fentanyl 4.125 mg) | N02AB03 | IPat | 02 | Fentanyl-Mepha 50 | transdermale Pflaster | Pansement matrice (Fentanyl 8.25 mg) | N02AB03 | IPat | 03 | Fentanyl-Mepha 75 | transdermale Pflaster | Pansement matrice (Fentanyl 12.375 mg) | N02AB03 | IPat | 04 | Fentanyl-Mepha 100 | transdermale Pflaster | Pansement matrice (Fentanyl 16.5 mg) | N02AB03 | IPat | 05 | Fentanyl-Mepha 12 | transdermale Pflaster | Pansement matrice (Fentanyl 2.063 mg) | N02AB03 | IPat |
|
|
|